Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
Active, not recruiting · NCT04219163 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-09-24 | NCT04219163 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baylor College of Medicine | 267 |
| Center for Cell and Gene Therapy, Baylor College of Medicine | 40 |
| The Methodist Hospital Research Institute | 124 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Texas Children's Hospital | Houston | United States | 187 |